Hannah Toellner
Respiratory Clinical Trials(AU)Queen Elizabeth University Hospital(GB)
Publications by Year
Research Areas
Respiratory Support and Mechanisms, Chronic Obstructive Pulmonary Disease (COPD) Research, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Neonatal Respiratory Health Research, Acute Kidney Injury Research
Most-Cited Works
- → Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis(2016)164 cited
- → Early clinical experiences with nintedanib in three UK tertiary interstitial lung disease centres(2017)54 cited
- → Assistive technologies for home NIV in patients with COPD: feasibility and positive experience with remote-monitoring and volume-assured auto-EPAP NIV mode(2021)10 cited
- → Two-way remote monitoring allows effective and realistic provision of home-NIV to COPD patients with persistent hypercapnia.(2020)3 cited
- → P178 Home remote-monitored auto-NIV: realistic provision and improved projected admission-free survival in patients with chronic hypercapnic COPD(2018)2 cited
- → Hypophosphatasia in adulthood - are patients really 'unaffected'(2019)
- → 2-way remote monitoring in adaptive mode allows effective and realistic provision of home Non-Invasive Ventilation(NIV) to patients with severe COPD(2018)
- → Hypophosphatasia in an infant: a differential diagnosis that should not be overlooked(2019)
- → Clinical experience with nintedanib for IPF in 3 UK tertiary referral centres(2016)